Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis

Neelam Hassan; Emma Jane Davies; Benjamin George Faber; Harsha Gunawardena

doi:10.1093/rheumatology/keaa698

Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis

Neelam Hassan, Emma Jane Davies, Benjamin George Faber, Harsha Gunawardena^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	E156-E158
Journal	Rheumatology (United Kingdom)
Volume	60
Issue number	5
Early online date	22 Nov 2020
DOIs	https://doi.org/10.1093/rheumatology/keaa698
Publication status	Published - 14 May 2021

Access to Document

10.1093/rheumatology/keaa698

Handle.net

Persistent link

Cite this

@article{568c284c949a449285de1b90d1da0708,

title = "Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis",

author = "Neelam Hassan and Davies, {Emma Jane} and Faber, {Benjamin George} and Harsha Gunawardena",

year = "2021",

month = may,

day = "14",

doi = "10.1093/rheumatology/keaa698",

language = "English",

volume = "60",

pages = "E156--E158",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis

AU - Hassan, Neelam

AU - Davies, Emma Jane

AU - Faber, Benjamin George

AU - Gunawardena, Harsha

PY - 2021/5/14

Y1 - 2021/5/14

UR - http://www.scopus.com/inward/record.url?scp=85106280779&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keaa698

DO - 10.1093/rheumatology/keaa698

M3 - Letter (Academic Journal)

C2 - 33221923

AN - SCOPUS:85106280779

SN - 1462-0324

VL - 60

SP - E156-E158

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 5

ER -

Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis

Access to Document

Handle.net

Other files and links

Cite this